GW Cancer Center

Mandi Pratt-Chapman, MA, associate center director for patient-centered initiatives and health equity at the GW Cancer Center, has been awarded a $4.125 million cooperative agreement to continue work with the Centers for Disease Control and Prevention to provide comprehensive technical…

The GW Cancer Center is pleased to announce that accomplished medical oncologist George Kim, MD, has joined the GW Cancer Center. He will serve as the director of the Gastrointestinal Cancers Program at the GW Cancer Center.

A team at the GW Cancer Center found that the deubiquitinating enzyme USP15 is a potential biomarker for treatments of breast and pancreatic cancers.

Vishal Patel, MD, director of the Cutaneous Oncology Program at the GW Cancer Center and assistant professor of dermatology at SMHS, spoke to Today about foot melanoma.

Rohan Fernandes, PhD, received more than $1.6 million from the National Institutes of Health to investigate nanoimmunotherapies for cancer

Members of the GW Cancer Center recently published several journal articles and patient-focused pieces highlighting the Center’s work in patient navigation and survivorship.

The GW Cancer Center is pleased to announce that Vishal A. Patel MD, FAAD, FACMS, an accomplished Mohs/Dermatologic surgeon and cutaneous oncologist, has joined the GW Cancer Center. He will serve as the director of the recently established Cutaneous Oncology Program.

A paper Oncology Issues journal paper, published by Adam Friedman, MD, director of translational research in the Department of Dermatology at SMHS, and MD student Stephanie Kao, is part of an effort to raise awareness of supportive oncodermatology.

A host of representatives from throughout the George Washington University (GW) health care community joined GW Cancer Center leadership on Oct.

Adam Friedman, MD, is the senior author of a study on the efficacy of nanoparticles in therapies for triple-negative breast cancer.